Процентные расходы Изменить Дата
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Cipla INR 170.3M 39M 2026-06
Compugen USD 1.35M 399K 2026-03
CSL USD 215M 111M 2025-12
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Grifols EUR 156.07M 31.46M 2025-09
Immunic 197K 222K 2025-12
Insmed USD 18.84M 1.24M 2026-06
Omeros USD 4.05M 5.16M 2024-09
OraSure Technologies 1.67M 1.13M 2025-12
Quidel USD 5.63B 5.58B 2026-03
Ultragenyx Pharmaceutical USD 22M 1000K 2026-06
United Therapeutics USD 2.9M 200K 2026-06